MedPath

Carwin Pharmaceutical Associates, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

FDA:12

Drug Approvals

POKONZA

Approval Date
Mar 22, 2024
FDA

Quflora Pediatric

Approval Date
Jan 10, 2024
FDA

TriStart DHA

Approval Date
Jan 9, 2024
FDA

RyVent

Approval Date
Jan 9, 2024
FDA

RELAFEN DS

Approval Date
Jan 8, 2024
FDA

RYCLORA

Approval Date
Jan 8, 2024
FDA

LOFENA

Approval Date
Jan 8, 2024
FDA

Diclofenac Potassium

Approval Date
Nov 8, 2023
FDA

Diclofenac Potassium

Approval Date
Nov 8, 2023
FDA

Quflora Pediatric Drops

Approval Date
Aug 3, 2017
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.